Welcome!

News Feed Item

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

LONDON, Jan. 22, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

EpiCast Report: Uveitis - Epidemiology Forecast to 2022

Summary

Uveitis is a serious eye condition that often results in permanent vision damage due to frequent recurrence even after treatment. It consists of a group of diseases that present with inflammation of the uvea, can occur in one or both eyes, and may also affect the adjacent tissues such as the retina, optic nerve, and vitreous humor. Symptoms may include blurred vision, dark, floating spots in the vision, eye pain, redness of the eye, and sensitivity to light. Uveitis has a wide variety of causes such as autoimmune disorders, infectious agents, or toxins; however, the cause is often unknown for a significant proportion of the cases.

In 2012, GlobalData epidemiologists forecast the 6MM had 223,559 incident cases of uveitis, 75% of which (168,264 cases) occurred in the US. Incident cases in the 6MM are expected to increase slightly to 245,353 cases by 2022, at the rate of 0.97% per year. In 2012, the 6MM had 665,778 prevalent cases of uveitis, which will increase to 730,913 cases in 2022 at the rate of 0.98% per year. The US also had the largest proportion of prevalent cases in 2012 (53.69%, 357,483 cases) out of all markets covered in this analysis. The forecast further shows anterior uveitis is the most common form of uveitis and non-infectious uveitis is the most common etiology among the 6MM.

This forecast provides detailed, granular, and clinically relevant segmentations of uveitis cases. The segmentations will allow for improved understanding of the disease and the ability to focus on specific subgroups within the disease. The analysis is further strengthened by the adherence to the standard clinical reporting guidelines from the International Uveitis Study Group (IUSG) and Standardization of Uveitis Nomenclature (SUN) Working Group. Using standard guidelines across the 6MM allows for meaningful comparisons across the markets and ensures these results will be relevant in reference to future studies, as the use of the guidelines are becoming more common in epidemiological research.

Scope

- This report provides an overview of the risk factors, comorbidities and the global epidemiological trends for uveitis in the six major markets (6MM: US, France, Germany, Italy, Spain, and UK). The report also includes a 10-year forecast of incident and prevalent cases of uveitis segmented by age, sex, primary anatomical location of inflammation (anterior, intermediate, posterior, panuveitis), and by etiology (infectious, non-infectious, idiopathic). Incident cases are further segmented by course of disease (acute, recurrent, chronic) and by severity (mild, moderate, severe).
- The uveitis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 6MM.

Reasons to buy

- Develop business strategies by understanding the trends shaping and driving the global uveitis market.
- Quantify patient populations in the global uveitis market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the patient segmentations that present the best opportunities for uveitis therapeutics in each of the markets covered.
- Identify the number of uveitis cases in each anatomical location category and in each etiology.

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Upcoming Reports 9
3 Epidemiology 10
3.1 Disease Background 10
3.2 Risk Factors and Comorbidities 11
3.2.1 Smoking increases risk of uveitis and increases complications 11
3.2.2 Juvenile idiopathic arthritis patients need regular ophthalmologic screenings 12
3.2.3 HLA-positive antigens are linked to certain types of uveitis 13
3.2.4 Uveitis is associated with various autoimmune, neurological, and infectious diseases 13
3.3 Global Trends 15
3.3.1 US 17
3.3.2 5EU 20
3.4 Forecast Methodology 22
3.4.1 Sources Used 25
3.4.2 Sources Not Used 30
3.4.3 Forecast Assumptions and Methods, Incident Cases 31
3.4.4 Forecast Assumptions and Methods, Prevalent Cases 32
3.4.5 Forecast Assumptions and Methods, Etiological and Anatomical Distribution 33
3.4.6 Forecast Assumptions and Methods, Course of Disease 36
3.4.7 Forecast Assumptions and Methods, Disease Severity 37
3.5 Epidemiological Forecast of Uveitis (2012-2022) 37
3.5.1 Incident Cases of Uveitis 37
3.5.2 Age-Specific Incident Cases of Uveitis 39
3.5.3 Sex-Specific Incident Cases 41
3.5.4 Age-Standardized Incidence Rates 42
3.5.5 Incident Cases by Anatomical Location 43
3.5.6 Incident Cases Segmented by Etiology 45
3.5.7 Course of Disease of Incident Uveitis Cases 48
3.5.8 Severity of Incident Uveitis Cases 50
3.5.9 Prevalent Cases of Uveitis 51
3.5.10 Age-Specific Prevalent Cases of Uveitis 53
3.5.11 Sex-Specific Prevalent Cases of Uveitis 54
3.5.12 Prevalent Cases by Anatomical Location 56
3.5.13 Prevalent Cases by Etiology 57
3.6 Discussion 59
3.6.1 Epidemiological Forecast Insight 59
3.6.2 Limitations of the Analysis 59
3.6.3 Strengths of the Analysis 61
4 Appendix 62
4.1 Bibliography 62
4.2 About the Authors 67
4.2.1 Epidemiologists 67
4.2.2 Reviewers 67
4.2.3 Global Director of Epidemiology and Health Policy 69
4.2.4 Global Head of Healthcare 69
4.3 About GlobalData 70
4.4 About EpiCast 70
4.5 Disclaimer 71

List of Tables

Table 1: Diseases Most Frequently Associated with Uveitis 14
Table 2: Distribution of Uveitis by Anatomical Location in Community and Referral Centers 20
Table 3: Distribution of Uveitis Cases by Anatomical Location of Inflammation, Europe 22
Table 4: IUSG/SUN Working Group Classification of Uveitis by Anatomical Location 23
Table 5: Clinical Classifications of Uveitis 23
Table 6: 6MM, Sources of Incidence and Prevalence of Uveitis in the 6MM 24
Table 7: Italy, Anatomy Classification Calculation 34
Table 8: US, Anatomical Locations of Uveitis for Incident and Prevalent Cases 36
Table 9: 6MM, Incident Cases of Uveitis, N (Column %), Select Years 2012-2022 38
Table 10: 6MM, Age-Specific Incident Cases of Uveitis, N (Row %), 2012 39
Table 11: 6MM, Sex-Specific Incident Cases of Uveitis, N (Row %), 2012 41
Table 12: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N (Row %), 2012 44
Table 13: 6MM, Incident Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 46
Table 14: 6MM, Incident Cases of Uveitis Segmented by Etiology and Anatomical Location, N, 2012 47
Table 15: 6MM, Incident Cases of Uveitis by Course of Disease, N (Row %), 2012 48
Table 16: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 50
Table 17: 6MM, Prevalent Cases of Uveitis, N (Column %), Select Years, 2012-2022 52
Table 18: 6MM, Age-Specific Prevalent Cases of Uveitis, N (Row %), 2012 53
Table 19: 6MM, Sex-Specific Prevalent Cases of Uveitis, N (Row %), 2012 55
Table 20: 6MM, Prevalent Cases of Uveitis by Anatomical Location of Inflammation, N (Row %), 2012 56
Table 21: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Age, N (Column %), 2012 57
Table 22: 6MM, Prevalent Cases of Uveitis Segmented by Etiology and Anatomical Location, 2012 58

List of Figures

Figure 1: US, Age Distribution of Study Populations Compared with the US General Population 18
Figure 2: US, Sex-Ratio of Study Populations Compared with the US General Population 19
Figure 3: 6MM, Incident Cases of Uveitis, N, 2012-2022 38
Figure 4: 6MM, Age-Specific Incident Cases of Uveitis, N, 2012 40
Figure 5: 6MM, Sex-Specific Incident Cases of Uveitis, N, 2012 42
Figure 6: 6MM, Age-Standardized Uveitis Incidence, Cases per 100,000 Population, Men and Women, 2012 43
Figure 7: 6MM, Incident Cases of Uveitis by Primary Anatomical Location of Inflammation, N, 2012 45
Figure 8: 6MM, Incident Cases of Uveitis by Course of Disease, N, 2012 49
Figure 9: 6MM, Incident Cases of Uveitis by Severity of Disease, N, 2012 51
Figure 10: 6MM, Prevalent Cases of Uveitis, N, 2012-2022 52
Figure 11: 6MM, Age-Specific Prevalent Cases of Uveitis, N, 2012 54
Figure 12: 6MM, Sex-Specific Prevalent Cases of Uveitis, N, 2012 55

Read the full report:
EpiCast Report: Uveitis - Epidemiology Forecast to 2022
http://www.reportbuyer.com/pharma_healthcare/healthcare/epicast_report_uveitis_epidemiology_forecast_2022.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=General_Medicine_and_Specialty_Medicine

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
JETRO showcased Japan Digital Transformation Pavilion at SYS-CON's 21st International Cloud Expo® at the Santa Clara Convention Center in Santa Clara, CA. The Japan External Trade Organization (JETRO) is a non-profit organization that provides business support services to companies expanding to Japan. With the support of JETRO's dedicated staff, clients can incorporate their business; receive visa, immigration, and HR support; find dedicated office space; identify local government subsidies; get...
"Akvelon is a software development company and we also provide consultancy services to folks who are looking to scale or accelerate their engineering roadmaps," explained Jeremiah Mothersell, Marketing Manager at Akvelon, in this SYS-CON.tv interview at 21st Cloud Expo, held Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA.
Both SaaS vendors and SaaS buyers are going “all-in” to hyperscale IaaS platforms such as AWS, which is disrupting the SaaS value proposition. Why should the enterprise SaaS consumer pay for the SaaS service if their data is resident in adjacent AWS S3 buckets? If both SaaS sellers and buyers are using the same cloud tools, automation and pay-per-transaction model offered by IaaS platforms, then why not host the “shrink-wrapped” software in the customers’ cloud? Further, serverless computing, cl...
All organizations that did not originate this moment have a pre-existing culture as well as legacy technology and processes that can be more or less amenable to DevOps implementation. That organizational culture is influenced by the personalities and management styles of Executive Management, the wider culture in which the organization is situated, and the personalities of key team members at all levels of the organization. This culture and entrenched interests usually throw a wrench in the work...
The now mainstream platform changes stemming from the first Internet boom brought many changes but didn’t really change the basic relationship between servers and the applications running on them. In fact, that was sort of the point. In his session at 18th Cloud Expo, Gordon Haff, senior cloud strategy marketing and evangelism manager at Red Hat, will discuss how today’s workloads require a new model and a new platform for development and execution. The platform must handle a wide range of rec...
"We view the cloud not as a specific technology but as a way of doing business and that way of doing business is transforming the way software, infrastructure and services are being delivered to business," explained Matthew Rosen, CEO and Director at Fusion, in this SYS-CON.tv interview at 18th Cloud Expo (http://www.CloudComputingExpo.com), held June 7-9 at the Javits Center in New York City, NY.
DXWorldEXPO LLC announced today that the upcoming DXWorldEXPO | CloudEXPO New York event will feature 10 companies from Poland to participate at the "Poland Digital Transformation Pavilion" on November 12-13, 2018.
The current age of digital transformation means that IT organizations must adapt their toolset to cover all digital experiences, beyond just the end users’. Today’s businesses can no longer focus solely on the digital interactions they manage with employees or customers; they must now contend with non-traditional factors. Whether it's the power of brand to make or break a company, the need to monitor across all locations 24/7, or the ability to proactively resolve issues, companies must adapt to...
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, led attendees through the exciting evolution of the cloud. He looked at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering m...
Without lifecycle traceability and visibility across the tool chain, stakeholders from Planning-to-Ops have limited insight and answers to who, what, when, why and how across the DevOps lifecycle. This impacts the ability to deliver high quality software at the needed velocity to drive positive business outcomes. In his general session at @DevOpsSummit at 19th Cloud Expo, Eric Robertson, General Manager at CollabNet, will discuss how customers are able to achieve a level of transparency that e...
As data explodes in quantity, importance and from new sources, the need for managing and protecting data residing across physical, virtual, and cloud environments grow with it. Managing data includes protecting it, indexing and classifying it for true, long-term management, compliance and E-Discovery. Commvault can ensure this with a single pane of glass solution – whether in a private cloud, a Service Provider delivered public cloud or a hybrid cloud environment – across the heterogeneous enter...
We all know that end users experience the internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices - not doing so will be a path to eventual ...
"DivvyCloud as a company set out to help customers automate solutions to the most common cloud problems," noted Jeremy Snyder, VP of Business Development at DivvyCloud, in this SYS-CON.tv interview at 20th Cloud Expo, held June 6-8, 2017, at the Javits Center in New York City, NY.
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
DXWorldEXPO LLC announced today that ICC-USA, a computer systems integrator and server manufacturing company focused on developing products and product appliances, will exhibit at the 22nd International CloudEXPO | DXWorldEXPO. DXWordEXPO New York 2018, colocated with CloudEXPO New York 2018 will be held November 11-13, 2018, in New York City. ICC is a computer systems integrator and server manufacturing company focused on developing products and product appliances to meet a wide range of ...